Rapid response to infliximab in severe pustular psoriasis, von Zumbusch type

International Journal of Dermatology

Volumn 41, Issue 7, 2002, Pages 449-452

  Newland, Meggan R ^a   Weinstein, Andrew ^a   Kerdel, Francisco ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b Department of Dermatology and Cutaneous Surgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BEXAROTENE; C REACTIVE PROTEIN; CEFAZOLIN; CHEMOKINE; CYCLOSPORIN; DAPSONE; DICHLORALPHENAZONE; ETRETIN; ETRETINATE; HEMOGLOBIN; HYDROCORTISONE; INFLIXIMAB; ISOMETHEPTENE; ISOTRETINOIN; METHOTREXATE; PARACETAMOL; PSORALEN; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANAMNESIS; CASE REPORT; CAUCASIAN; CONFERENCE PAPER; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG INFUSION; FEMALE; HEMATOCRIT; HEMODYNAMIC PARAMETERS; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MIGRAINE; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PREGNANCY; PUSTULAR PSORIASIS; PUSTULE; PUVA; SKIN DISEASE; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; THROMBOCYTE; ULTRAVIOLET B RADIATION;

ADULT; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; PSORIASIS; REACTION TIME; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0036060427     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01543.x     Document Type: Conference Paper

References (6)

1. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial
2. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory disease
3. Elevated tumour necrosis factor-alpha biological activity in psoriatic skin lesions
4. Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions
5. Psoriasis und pustuloses Exanthem
6. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases